The California National Primate Research Center hosted the 40th Annual Symposium on Nonhuman Primate Models for AIDS from October 10 -13, 2023, at the University of California Davis Activities and Recreation Center in Davis, California. This meeting was preceded by the 7th annual Translational HIV Vaccine ESI Conference, organized on October 9-10 by the HIV Vaccine Trials Network at the UC-Davis Conference Center. Both meetings had a lot of synergy and cross-networking.
The Annual Symposium served as a scientific forum for the exchange of information, including new research findings and scientific perspectives, among HIV/AIDS and other infectious disease investigators whose research includes studies in nonhuman primates (NHPs). The conference was widely publicized and attracted scientists from around the world, including early-stage investigators, established faculty, veterinarians, veterinary technicians, postdoctoral fellows, and graduate students. This meeting is the only one of its kind in the world. The symposium included research presentations on HIV/SIV and other infectious diseases, and updates on latest technologies/-omics with broader applications using nonhuman primate models. With 38 million people currently estimated to be living with HIV worldwide, the need to develop better treatments and interventions to prevent and/or cure HIV infection remains critical.
The 41st Annual Symposium on Nonhuman Primate Models for AIDS will be hosted by the Tulane National Primate Research Center. This in person meeting will take place from October 22-25, 2024, at the Westin New Orleans in the vibrant city of New Orleans, Louisiana. This annual symposium is the leading forum for the exchange of the latest developments in HIV/AIDS research in nonhuman primates (NHPs) and attracts more than 300 of the world’s foremost infectious disease researchers. Scientists, veterinarians, faculty, graduate students, and investigators of all levels attend this meeting to share their findings and advancements in intervention, treatment, prevention and/or cures for HIV and its coinfections.